Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Medifast (MED) Long-Term Debt Repayments (2016)

Medifast's Long-Term Debt Repayments history spans 7 years, with the latest figure at $56000.0 for Q4 2016.

For Q4 2016, Long-Term Debt Repayments fell 31.71% year-over-year to $56000.0; the TTM value through Dec 2016 reached $219000.0, down 14.12%, while the annual FY2016 figure was $219000.0, 14.12% down from the prior year.
Long-Term Debt Repayments reached $56000.0 in Q4 2016 per MED's latest filing, up from $55000.0 in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $3.4 million in Q1 2013 to a low of $53000.0 in Q1 2016.
Average Long-Term Debt Repayments over 5 years is $289050.0, with a median of $57500.0 recorded in 2015.
Peak YoY movement for Long-Term Debt Repayments: soared 1167.04% in 2013, then crashed 98.39% in 2014.
A 5-year view of Long-Term Debt Repayments shows it stood at $147000.0 in 2012, then plummeted by 63.27% to $54000.0 in 2013, then grew by 3.7% to $56000.0 in 2014, then soared by 46.43% to $82000.0 in 2015, then plummeted by 31.71% to $56000.0 in 2016.
Per Business Quant, the three most recent readings for MED's Long-Term Debt Repayments are $56000.0 (Q4 2016), $55000.0 (Q3 2016), and $55000.0 (Q2 2016).